$95.51 Original price was: $95.51.$54.00Current price is: $54.00.
By Michael J. Winkelman, Ben Sessa MD
Researchers, program administrators, and practicing clinicians explain the most recent developments in using psychedelic substances to treat psychological, physiological, and social problems.
More than a decade ago, the U.S. government lifted its ban on all testing of psychedelic substances. Winkelman and Sessa now provide updated scientific research and applications of these substances, now moving into approved categories of medicine. The text is an up-to-date assessment of the latest advances in the field of psychedelic medicine, covering the use of LSD, psilocybin, MDMA, ayahuasca, and other substances to augment psychotherapies for a range of disorders. It discusses medical and psychiatric concerns, clinical efficacy and safety, ethical considerations, and neuroscience findings regarding the psychedelic compounds.
Overview of psychiatric applications of psychedelics
Treatments for addictions and depressive disorders
Effects of psychedelics on inflammation and neuroplasticity
Evidence for clinical applications of DMT, ayahuasca, and cannabidiol
Psychedelic treatment of sociopathic disorders
Microdosing psychedelics
Training psychedelic therapists
Community-based harm reduction approaches to managing psychedelic crises
Publisher: Praeger (March 22, 2019)
Language: English
Format: Hardcover
Pages: 400
ISBN-10: 1440864101
ISBN-13: 978-1440864100
Language | |
---|---|
Author |
Fermentum tempor cubilia risus tellus massa dis consectetur dolor.
WhatsApp Chat Oniline